KENNETH S. CRAGUN
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
BRENDA AGIUS, CARLOS CAPONERA, HEATH B CLARKE, HEATH B. CLARKE, KENNETH CRAGUN, KENNETH S CRAGUN, STANLEY B. CRAIR, NORMAN JR. K FARRA, NORMAN FARRA JR., NORMAN K. FARRA, JR., PHILIP K FRICKE, PHILIP K. FRICKE, DAVID HUGHES, THEODORE E. LAVOIE, JOHN PAYNE, MICHAEL PLONSKI, JOHN REHFELD, JOHN E REHFELD, JOHN E. REHFELD, SCOTT REINKE, LOWELL W ROBINSON, MICHAEL A SAWTELL, MICHAEL A. SAWTELL, FREDERICK THIEL, FREDERICK G THIEL
EXECUTIVE OFFICER
DIRECTOR
PHILLIP J. BOND, NICOLAS CARY, JEFF CLAYBORNE, JEFFREY R. CLAYBORNE, LEIGH COLLIER, RORY CUTAIA, RORY J CUTAIA, RORY J. CUTAIA, JAMES P GEISKOPF, JAMES P. GEISKOPF, RON GILLYARD, TAL GOLAN, JUDITH HAMMERSCHMIDT, NANCY HEINEN, TUCKER HIGHFIELD, PETER JENSEN, VERONIKA KAPUSTINA, CRAGUN S. KENNETH, PAUL MCDONALD, AARON MEYERSON, EDMUND C. MOY, SARAH OLSEN, MICHAEL PSOMAS, MICHAEL T. PSOMAS, BILL J. RIVARD, DAVID ROSE, EVAN SOHN, MANUEL STOTZ, KIM WATSON
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER TECHNOLOGY
SERVICES-PERSONAL SERVICES [7200]
DECLINE TO DISCLOSE
Equity
2020-02-25
D
OTHER TECHNOLOGY
SERVICES-PERSONAL SERVICES [7200]
DECLINE TO DISCLOSE
Equity
2019-08-14
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-03-04
D
OTHER TECHNOLOGY
SERVICES-BUSINESS SERVICES, NEC [7389]
$25,000,001 - $100,000,000
Equity
2011-07-08

